DNM1L expression was significantly higher in BRCA, CHOL, COAD, ESCA, HNSC, LIHC, LUAD, LUSC, PCPG, and STAD than in paraneoplastic tissues, and it exhibited low levels in GBM, KIRC, KIRP, PRAD, SKCM, and THCA. Here, DNM1L is linked to glioblastoma.